Nov 24, 2020
Since 2017 we have seen the slow and steady adoption of User Experience (UX) within the life sciences. User Experience is an evidence-based design process that centres on the behaviours and needs of users.
The clear benefits of UX offered in the retail and consumer sectors have been slow to percolate to other more complex sectors such as the life sciences. As the benefits of adoption of UX come to be realised, we see steady and strong growth in the R&D life sciences sector.
By Jacek Ziemski, Simon Fortenbacher, James Hoeksma, Jan Taubert, Roger Attrill, Paula de Matos, Andre Richter and Julie Morrison
If you'd like to view the original article then follow the link below:
You can also download the original article pdf here:
For more information on Drug Discovery World, head to: